1. Home
  2. CMT vs MCRB Comparison

CMT vs MCRB Comparison

Compare CMT & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core Molding Technologies Inc

CMT

Core Molding Technologies Inc

HOLD

Current Price

$21.28

Market Cap

180.0M

ML Signal

HOLD

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$14.65

Market Cap

162.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMT
MCRB
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
180.0M
162.7M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CMT
MCRB
Price
$21.28
$14.65
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$14.33
AVG Volume (30 Days)
25.7K
84.6K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.93
0.62
Revenue
$261,619,000.00
$351,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
$22.99
$23.66
Revenue Growth
N/A
N/A
52 Week Low
$12.25
$6.53
52 Week High
$22.29
$29.98

Technical Indicators

Market Signals
Indicator
CMT
MCRB
Relative Strength Index (RSI) 65.36 42.87
Support Level $19.78 $14.03
Resistance Level $21.43 $15.41
Average True Range (ATR) 0.85 0.88
MACD 0.09 -0.15
Stochastic Oscillator 100.00 30.49

Price Performance

Historical Comparison
CMT
MCRB

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: